SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (unres) Regulatory News (SPSY)

Share Price Information for Spectra (unres) (SPSY)

Share Price is delayed by 15 minutes
Get Live Data
182.50    2.00 (1.11%)
Bid:
180.00
Ask:
185.00
Spread: 5.00 (2.778%)
Market Cap: £88.37m
SPSY Live PriceLast checked at - London Stock Exchange

Intraday Spectra (unres) Share Chart

Share Buyback Programme

25 Nov 2025 07:00

RNS Number : 8151I
Spectra Systems Corporation
25 November 2025
 

Spectra Systems Corporation

(The "Company" or "Spectra Systems")

Share Buyback Programme

Spectra Systems, a leader in machine-readable high speed banknote authentication, brand protection technologies and gaming security software, announces the launch of an initial share buyback programme of unrestricted common shares of US$0.01 each ("Common Shares") to repurchase up to US$350,000 worth of Common Shares (the "Buyback Programme"), effective from today.

The Board considers the Buyback Programme to be in the best interests of all shareholders, given the cash generative nature of the business and the surplus cash the Company holds. It is also consistent with the Board's desire to increase shareholder value/ returns.

The Company has appointed its broker, Zeus Capital Limited ("Zeus"), to manage the Buyback Programme to repurchase Ordinary Shares on its behalf and entered into an irrevocable and non-discretionary arrangement on 24 November 2025 with Zeus, to enable Zeus to conduct the Buyback Programme on a broker-managed basis. Zeus will make trading decisions in relation to the Buyback Programme independently of the Company, within certain defined parameters.

The Buyback Programme commences today and will end on the earlier of the date upon which the aggregate consideration paid for Common Shares reaches US$350,000 or 5 December 2025 (the "Buyback Period"). During the Buyback Period the Company has no power to invoke any changes to the authority and any purchases will be undertaken by Zeus, acting independently of, and uninfluenced by the Company.

Common Share repurchases will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volume. The Buyback Programme is in accordance with the Company's general authority to purchase its own shares under Delaware General Corporation Law. The price paid for Common Shares under the Buyback Programme will be no more than: a) 105 per cent. of the average trading price of the Ordinary Shares as derived from the middle market quotations for an Ordinary Share on the London Stock Exchange Daily Official List for the five trading days immediately preceding the date on which an Ordinary Share is contracted to be purchased; and b) £1.35.

Under the Buyback Programme, the repurchased shares will be cancelled.

The Buyback Programme will be conducted within the parameters of the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation 2016/1052/EU (each as in force in the UK from time to time, including where relevant pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2019.

The Company will make further announcements in due course following any share purchases conducted through the Buyback Programme.

Following this announcement, the issued share capital of the Company remains unchanged at:

· 47,758,431 shares in the unrestricted line ISIN number US84756T1060 (AIM:SPSY); and

· 542,258 shares in the Regulation S stock line ISIN number USU8457D1091 (AIM:SPSC)

Spectra Systems has no Shares in treasury, therefore 48,300,689 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

The Company confirms that it currently has no unpublished price sensitive information.

Enquiries:

 

Spectra Systems Corporation 

Dr. Nabil Lawandy, Chief Executive Officer 

Tel: +1 (0)401 274 4700 

Zeus (Nominated Adviser and Joint Broker)

James Joyce / James Bavister (Investment Banking) 

Fraser Marshall (Corporate Broking) 

 

Allenby Capital Limited (Joint Broker) 

Nick Naylor/James Reeve (Corporate Finance) 

Amrit Nahal (Sales and Corporate Broking)

Tel: +44 (0)20 3829 5000

 

Tel: +44 (0)20 3328 5665 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPGBWGUPAPUC
Date   Source Headline
18th Jul 20177:00 amRNSRegulatory Approval for TruBrand Materials, China
7th Jul 20177:08 amRNSHolding(s) in Company
26th Jun 20177:00 amRNSIssuance of Patents
22nd Jun 20172:18 pmRNSPosting of Annual Report and Accounts
18th May 20173:47 pmRNSExercise of Options
5th May 20172:01 pmRNSExercise of Options
13th Apr 201711:26 amRNSExercise of Options
30th Mar 20177:00 amRNSPreliminary Results
17th Mar 20177:00 amRNSAppointment of Chief Financial Officer
23rd Jan 20177:00 amRNSAppointment of Chief Financial Officer
11th Jan 20177:00 amRNSIssuance of Patents
4th Jan 20177:00 amRNSTrading Update
5th Dec 20167:00 amRNSResignation of Chief Financial Officer
1st Dec 20167:00 amRNSAnnual General Meeting Postponed
3rd Oct 20167:00 amRNSNew Five Year Contract with G7 Central Bank
21st Sep 20165:06 pmRNSHolding(s) in Company
19th Sep 20167:00 amRNSInterim Results for 6 Months ended 30 June 2016
7th Sep 20167:00 amRNSInterim Results Pre-announcement
24th Jun 20167:00 amRNSPosting of Annual Report and Accounts
31st May 20167:00 amRNSGrant of share options
25th May 20165:12 pmRNSHolding(s) in Company
5th May 20167:00 amRNSFirst TruBrand customer
18th Apr 20169:41 amRNSHolding(s) in Company
18th Apr 20167:00 amRNSPreliminary Results
16th Feb 20167:00 amRNSExpected grant of share options
8th Feb 20167:00 amRNSTrading update and expected grant of share options
29th Jan 20167:00 amRNS$3m Acquisition of Key Specialty Phosphour Assets
27th Jan 20164:01 pmRNSHolding(s) in Company
17th Dec 20154:34 pmRNSRemoval of Restrictions from Common Stock
30th Nov 20157:00 amRNSHolding(s) in Company
17th Nov 20157:00 amRNSAGM Postponement
4th Nov 20154:28 pmRNSHolding(s) in Company
4th Nov 20151:57 pmRNSRemoval of Restrictions from Common Stock
16th Oct 20159:53 amRNSRemoval of Restrictions from Common Stock
2nd Oct 20153:17 pmRNSNotice of AGM
10th Sep 20152:30 pmRNSHolding(s) in Company
1st Sep 20154:41 pmRNSSettlement of Common Shares
1st Sep 20157:03 amRNSInterim results for 6 months ended 30 June 2015
14th Aug 20152:42 pmRNSRemoval of Restrictions from Common Stock
14th Aug 20157:00 amRNSModified Covert Materials Supply Contract
3rd Jul 20157:00 amRNSHolding(s) in Company
2nd Jul 20157:00 amRNSContract Win
19th Jun 201511:17 amRNSPosting of Annual Report and Accounts
16th Jun 20154:06 pmRNSRemoval of Restrictions from Common Stock
19th May 20158:46 amRNSRemoval of Restrictions from Common Stock
18th May 20153:50 pmRNSHolding(s) in Company
22nd Apr 20157:31 amRNSPreliminary Results
2nd Apr 20153:05 pmRNSRemoval of Restrictions from Common Stock
19th Mar 20152:23 pmRNSRemoval of Restrictions from Common Stock
5th Mar 20158:40 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.